US3772021A - Process for the development of silver halide light-sensitive material - Google Patents
Process for the development of silver halide light-sensitive material Download PDFInfo
- Publication number
- US3772021A US3772021A US00079627A US3772021DA US3772021A US 3772021 A US3772021 A US 3772021A US 00079627 A US00079627 A US 00079627A US 3772021D A US3772021D A US 3772021DA US 3772021 A US3772021 A US 3772021A
- Authority
- US
- United States
- Prior art keywords
- compound
- developing
- silver halide
- development
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 37
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 31
- 239000004332 silver Substances 0.000 title claims abstract description 31
- -1 silver halide Chemical class 0.000 title claims abstract description 31
- 239000000463 material Substances 0.000 title claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims abstract description 67
- 239000000126 substance Substances 0.000 claims abstract description 7
- 239000000839 emulsion Substances 0.000 claims description 27
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 10
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- ZFIQGRISGKSVAG-UHFFFAOYSA-N 4-methylaminophenol Chemical compound CNC1=CC=C(O)C=C1 ZFIQGRISGKSVAG-UHFFFAOYSA-N 0.000 claims description 3
- QNGVNLMMEQUVQK-UHFFFAOYSA-N 4-n,4-n-diethylbenzene-1,4-diamine Chemical compound CCN(CC)C1=CC=C(N)C=C1 QNGVNLMMEQUVQK-UHFFFAOYSA-N 0.000 claims description 3
- 206010070834 Sensitisation Diseases 0.000 claims description 3
- 230000008313 sensitization Effects 0.000 claims description 3
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 9
- 125000000217 alkyl group Chemical group 0.000 abstract description 8
- 125000005037 alkyl phenyl group Chemical group 0.000 abstract description 4
- 150000001450 anions Chemical group 0.000 abstract description 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 26
- 230000035945 sensitivity Effects 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 239000010410 layer Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 8
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229940125758 compound 15 Drugs 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 235000010265 sodium sulphite Nutrition 0.000 description 4
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- 101150065749 Churc1 gene Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 3
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 3
- 229910021538 borax Inorganic materials 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 229940125797 compound 12 Drugs 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940125810 compound 20 Drugs 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 235000010339 sodium tetraborate Nutrition 0.000 description 3
- 239000004328 sodium tetraborate Substances 0.000 description 3
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 3
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- ZVNPWFOVUDMGRP-UHFFFAOYSA-N 4-methylaminophenol sulfate Chemical compound OS(O)(=O)=O.CNC1=CC=C(O)C=C1.CNC1=CC=C(O)C=C1 ZVNPWFOVUDMGRP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 2
- 102100038239 Protein Churchill Human genes 0.000 description 2
- 229910021612 Silver iodide Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 235000010338 boric acid Nutrition 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 108010041382 compound 20 Proteins 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 2
- 230000001235 sensitizing effect Effects 0.000 description 2
- 229940045105 silver iodide Drugs 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- LUMLZKVIXLWTCI-NSCUHMNNSA-N (e)-2,3-dichloro-4-oxobut-2-enoic acid Chemical compound OC(=O)C(\Cl)=C(/Cl)C=O LUMLZKVIXLWTCI-NSCUHMNNSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- JAAIPIWKKXCNOC-UHFFFAOYSA-N 1h-tetrazol-1-ium-5-thiolate Chemical compound SC1=NN=NN1 JAAIPIWKKXCNOC-UHFFFAOYSA-N 0.000 description 1
- XPAZGLFMMUODDK-UHFFFAOYSA-N 6-nitro-1h-benzimidazole Chemical compound [O-][N+](=O)C1=CC=C2N=CNC2=C1 XPAZGLFMMUODDK-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical group N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- ZUIVNYGZFPOXFW-UHFFFAOYSA-N chembl1717603 Chemical compound N1=C(C)C=C(O)N2N=CN=C21 ZUIVNYGZFPOXFW-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical compound O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000002344 gold compounds Chemical class 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-O hydron;quinoline Chemical compound [NH+]1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-O 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- ZAKLKBFCSHJIRI-UHFFFAOYSA-N mucochloric acid Natural products OC1OC(=O)C(Cl)=C1Cl ZAKLKBFCSHJIRI-UHFFFAOYSA-N 0.000 description 1
- DOWVMJFBDGWVML-UHFFFAOYSA-N n-cyclohexyl-n-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide Chemical compound C1=NC(C=2C=[N+]([O-])C=CC=2)=CN1C(=O)N(C)C1CCCCC1 DOWVMJFBDGWVML-UHFFFAOYSA-N 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- OENLEHTYJXMVBG-UHFFFAOYSA-N pyridine;hydrate Chemical compound [OH-].C1=CC=[NH+]C=C1 OENLEHTYJXMVBG-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229940076133 sodium carbonate monohydrate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/04—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
- G03C1/043—Polyalkylene oxides; Polyalkylene sulfides; Polyalkylene selenides; Polyalkylene tellurides
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/06—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with non-macromolecular additives
- G03C1/08—Sensitivity-increasing substances
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/29—Development processes or agents therefor
- G03C5/305—Additives other than developers
- G03C5/3056—Macromolecular additives
Definitions
- ABSTRACT A process for the development of silver halide photographic materials which comprises developing photographic materials in the presence of a compound of the formula:
- R is a hydrogen atom, an alkyl group, an alkylphenyl group or (CI-I ),,,OR, R is a hydrogen atom, an alkyl group or m is a positive integer of at least 2, n is O or a positive integer, p is l or 2, X is an anion, and Z is an organic chemical structure necessary for completing a heterocyclic ring together with N, is disclosed.
- the scope of the present invention also extends to the developed product formed, the developing compounds employed and their process of preparation.
- R is a hydrogen atom, an alkyl group, an alkylphenyl group or -(CI-I -OR', R being a hydrogen atom, an alkyl group or m being an integer of at least 2, n being or a positive integer, p being 1 or 2, X being an anion, and Z being an organic chemical structure for completing the heterocyclic ring together with N such as pyridinium, imidazolium or quinolinium ring.
- the compound 2 is obtained after the elimination of the excess pyridine by distillation.
- Synthesis of Compound 8 l Mole of l-ethoxy-3-chloropropanol-2 synthesized in the manner as in the above example and 1 mole of Z-methylimidazole are dissolved in dioxane and the resulting solution is heated for about hours. The reaction mixture is then washed with ethyl acetate to obtain the Compound 8.
- the ether parts are collected, dried by anhydrous sodium sulfate and, after removal of ether by distillation, refined to obtain a monoglycidyl ether of a boiling point of l14-5C/2.5 mm Hg and a diglycidyl ether of a boiling point of l23-4C/2.5 mm Hg.
- One mole of the diglycidyl ether is dissolved in 600 cc of dioxane and gaseous hydrogen chloride is then introduced into the solution with stirring and cooling until hydrogen chloride becomes excessive.
- the solution is then allowed to stand overnight.
- the solution is heated on a steam bath for about 1 hour, and nitrogen gas is then introduced to eliminate any excess of hydrogen chloride.
- reaction product After elimination of dioxane under reduced pressure, the reaction product is refluxed in an excess of hydrous pyridine for 14 hours. During the reflux, the reaction mixture gradually separated to two phases. After removal of the lower layer, pyridine was elirninated from the upper layer. The residue of upper layer is dissolved in a small amount of water and then washed with ether to obtain the Compound 15.
- the compounds l,3,4,5 and 6 are synthesized by using methanol, propanol, butanol, hexanol and tetradecyl alcohol respectively in the manner as prescribed in the synthesis of the Compound 2.
- the compounds 7,9,l0 and 1 l are synthesized in the manner as prescribed in the synthesis of the Compound 8 by use of methanol, propanol, butanol and hexanol, respectively.
- the Compound 13 is synthesized in the similar manner as in the synthesis of the Compound 18 by use of the monoglycidyl ether.
- the Compounds 14 and 16 are synthesized in the same manner as in the synthesis of the Compound 15.
- the compounds of the present invention are applicable to the ordinary silver halide photosensitive materials, such as, e.g., black and white positive materials of relatively low sensitivity, black and white negative materials of relatively high sensitivity, X-ray materials and color materials.
- the known amine compounds and quaternary salt compounds have development accelerating effects and sensitivity increasing effects, they have a drawback of increasing fog.
- the compounds of the present invention are free from the drawback of increasing fog and moreover considerably accelerate the rate of development and increase the sensitivity.
- the developing solution in which the compounds of the present invention are used are the ordinary developing solutions which contain at least one of the following compounds, and their known derivatives, as the developing agents: hydroquinone, l-phenyl-3 pyrazolidone, N-methyl-p-aminophenol, N,N-diethylp-phenylenediamine.
- the developing solutions may contain, in addition to the developing agent, preservatives, such as sodium sulfite, ascorbic acid or hydroxylamine, pH adjusting or bufiering agent, such as sodium sulfate, boric acid, borax, sodium hydroxide, sodium carbonate or trisodium phosphate, development retarders, such as potassium bromide or potassium iodide, or anti-fogging agents, such as 6- nitrobenzimidazole, benzotriazole or 1 mercaptotetrazole.
- preservatives such as sodium sulfite, ascorbic acid or hydroxylamine
- pH adjusting or bufiering agent such as sodium sulfate, boric acid, borax, sodium hydroxide, sodium carbonate or trisodium phosphate
- development retarders such as potassium bromide or potassium iodide
- anti-fogging agents such as 6- nitrobenzimidazole, benzotriazole or 1 mercaptotetrazole
- the compounds of the present invention may be effectively incorporated in a developing solution, in a bath preceding the development step andfor in a silver halide emulsion. Satisfactory results are obtainable, in most cases, by use of one of the compounds of the present invention, though, in certain cases, an increased effect may be obtained by a combined use of two or more of the compounds of the present invention.
- the compound of the present invention is usually used in a concentration of from 0.01 to 20 parts/l and preferably 0.1 to 10 parts/l, depending upon composition of the solution.
- the compound in a silver halide emulsion, it is preferable to incorporate these compounds in an amount of from 0.01 to 20 parts per mole of silver halide, depending on the composition of the emulsion and/or the method of sensitizing applied to the emulsion.
- the compound may be added to the emulsion in any stage of the preparation thereof, best results are obtained when it is added to the emulsion between chemical sensitization and coating.
- the compound may be incorporated in a contiguous layer such as a protective layer instead of incorporating directly in the emulsion layer. In this case, the compound in the contiguous layer migrates immediately or during the later processes including development into the emulsion layer.
- the silver halide emulsion used in the practice of the present invention includes those containing silver chloride, silver bromide, silver chlorobromide, silver iodide, silver iodobromide or silver chloro-iodobromide.
- the emulsion may be chemically sensitized by means of an unstable sulfur compound and/or a gold compound.
- the emulsion may be spectrally sensitized by means of, e.g., a cyanine dye or merocyanine dye.
- the emulsion may be stabilized by a heterocyclic compound such as, e.g., 4-hydroxy-6-methyl-1,3,3a, 7- tetrazaindene or l-phenyl-5-mercaptotetrazole.
- the emulsion may be hardened by known hardeners such as formaldehyde or mucochloric acid or may contain a surface active agent as a coating aid.
- the emulsion may contain a color coupler capable of reacting with an oxidized product of an aromatic primary amine developing agent to form a color image.
- EXAMPLE 1 A commercially available fine grain positive cine film comprising a fine grain silver chloroiodobromidegelatin emulsion was developed at 20C in a developing solution of the following composition.
- the developing time could be shortened by addition of a compound of the present invention (Compoundto the developing solution as indicated in the following Table I.
- a compound of the present invention Compoundto the developing solution as indicated in the following Table I.
- another test strip which was developed for 8 minutes in the presence of the compounds of the present invention showed an increase in sensitivity as indicated also in the Table 1.
- the photographic characteristics in the case where a known quaternary ammonium salt compound-l7 was added were also indicated in the Table l.
- EXAMPLE 2 A commercial high speed film comprising a spectrally sensitized silver iodobromide-gelatin emulsion was developed at C in a developing solution of the following composition.
- a commercially available fine grain positive cine film comprising a fine grain silver chloroiodobromidegelatin emulsion was developed using the same developing solution as in Example 1 at 20C for 8 minutes. Separately, other pieces of the film were developed in the same manner using the same solution except that a compound of the present invention (Compound 1 to 5) or a Compound 20 which was outside the scope of the present invention had been added for comparison. The results obtained were summarized in the Table-4.
- An aqueous solution of the Compound 12 or 15 of the present invention was added to a silver iodobromide-gelatin emulsion containing 3.0 mol% of silver iodide (1g per kg-cm.) and coated on a film support and dried.
- the test films thus obtained were developed at 20C for 8 minutes in the same developing solution as in Example 1.
- the photographic characteristics obtained were indicated in the Table-6.
- a process for the development of silver halide photographic materials which comprises developing said photographic materials in the presence of a compound which increases the rate of development and effective sensitivity without increasing fog, said compound being represented by the formula:
- R is a hydrogen atom, an alkyl group, an alkylphenyl group or -(CH -OR, R is a hydrogen atom, an alkyl group or m is a positive integer of at least 2, n is 0 or a positive integer, with the proviso that when R is a hydrogen atom, n is a positive integer, p is 1 or 2, X is an anion, and Z is an organic chemical structure necessary for completing a heterocyclic ring together with N selected from the group consisting of pyridinium, imidazolium and quinolinium.
- n is an integer of 0 to 3
- m is an integer of 2 to 6.
- said developing solution contains at least one member selected from the group consisting of hydroquinone, l-phenyl-3 -pyrazolidone, N-methyl-p-aminophenol and N,N-diethyl p-phenylenediamine.
- concentration of developing compound ranges from 0.01 to 20 parts/- mole of silver in said emulsion.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP44080988A JPS4843136B1 (fr) | 1969-10-09 | 1969-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3772021A true US3772021A (en) | 1973-11-13 |
Family
ID=13733863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US00079627A Expired - Lifetime US3772021A (en) | 1969-10-09 | 1970-10-09 | Process for the development of silver halide light-sensitive material |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3772021A (fr) |
| JP (1) | JPS4843136B1 (fr) |
| BE (1) | BE757216A (fr) |
| DE (1) | DE2049754A1 (fr) |
| FR (1) | FR2065165A5 (fr) |
| GB (1) | GB1298965A (fr) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0106306A2 (fr) | 1982-10-14 | 1984-04-25 | Fuji Photo Film Co., Ltd. | Matériaux photographiques couleur à l'halogénure d'argent |
| EP0112162A2 (fr) | 1982-12-13 | 1984-06-27 | Konica Corporation | Matériel photographique photosensible aux halogénures d'argent |
| EP0147854A2 (fr) | 1983-12-29 | 1985-07-10 | Fuji Photo Film Co., Ltd. | Matériel photosensible aux hologènures d'argent |
| EP0209118A2 (fr) | 1985-07-17 | 1987-01-21 | Konica Corporation | Matériau photographique à l'halogénure d'argent |
| US6071688A (en) * | 1998-07-29 | 2000-06-06 | Eastman Kodak Company | Providing additives to a coating composition by vaporization |
| US7250202B1 (en) | 1998-06-18 | 2007-07-31 | Ilford Imaging Ch Gmbh | Recording sheets for ink jet printing |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011135673A1 (fr) * | 2010-04-27 | 2011-11-03 | 荏原ユージライト株式会社 | Nouveau composé et son utilisation |
| JP2012116802A (ja) * | 2010-12-02 | 2012-06-21 | Nitto Boseki Co Ltd | イオン液体及びその製造方法 |
| US10918624B2 (en) | 2019-06-03 | 2021-02-16 | Imam Abdulrahman Bin Faisal University | Anti-cancer azole compounds |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2648604A (en) * | 1951-12-28 | 1953-08-11 | Gen Aniline & Film Corp | Photographic developer containing a pyridinium salt and process of development |
| US2940851A (en) * | 1957-11-27 | 1960-06-14 | Eastman Kodak Co | Sensitization of photographic emulsions |
-
0
- BE BE757216D patent/BE757216A/fr unknown
-
1969
- 1969-10-09 JP JP44080988A patent/JPS4843136B1/ja active Pending
-
1970
- 1970-10-08 FR FR7036329A patent/FR2065165A5/fr not_active Expired
- 1970-10-09 US US00079627A patent/US3772021A/en not_active Expired - Lifetime
- 1970-10-09 GB GB48173/70A patent/GB1298965A/en not_active Expired
- 1970-10-09 DE DE19702049754 patent/DE2049754A1/de active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2648604A (en) * | 1951-12-28 | 1953-08-11 | Gen Aniline & Film Corp | Photographic developer containing a pyridinium salt and process of development |
| US2940851A (en) * | 1957-11-27 | 1960-06-14 | Eastman Kodak Co | Sensitization of photographic emulsions |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0106306A2 (fr) | 1982-10-14 | 1984-04-25 | Fuji Photo Film Co., Ltd. | Matériaux photographiques couleur à l'halogénure d'argent |
| EP0112162A2 (fr) | 1982-12-13 | 1984-06-27 | Konica Corporation | Matériel photographique photosensible aux halogénures d'argent |
| EP0147854A2 (fr) | 1983-12-29 | 1985-07-10 | Fuji Photo Film Co., Ltd. | Matériel photosensible aux hologènures d'argent |
| EP0209118A2 (fr) | 1985-07-17 | 1987-01-21 | Konica Corporation | Matériau photographique à l'halogénure d'argent |
| US7250202B1 (en) | 1998-06-18 | 2007-07-31 | Ilford Imaging Ch Gmbh | Recording sheets for ink jet printing |
| US6071688A (en) * | 1998-07-29 | 2000-06-06 | Eastman Kodak Company | Providing additives to a coating composition by vaporization |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1298965A (en) | 1972-12-06 |
| DE2049754A1 (de) | 1971-04-29 |
| JPS4843136B1 (fr) | 1973-12-17 |
| FR2065165A5 (fr) | 1971-07-23 |
| BE757216A (fr) | 1971-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2716062A (en) | 4-hydroxy-6-alkyl-1, 3, 3a, 7-tetrazaindene stabilizers for emulsions sensitized with alkylene oxide polymers | |
| JPH02170155A (ja) | 硬調現像用の写真要素及び方法 | |
| US3301678A (en) | Process for stabilizing photographic images with heat | |
| US3772021A (en) | Process for the development of silver halide light-sensitive material | |
| US3954478A (en) | Silver halide emulsion containing an alkenyl benzothiazolium salt as stabilizer | |
| US3241967A (en) | Photographic developer composition containing 2-hydroxymethyl-3-pyrazolidones | |
| US3650749A (en) | Photographic development | |
| US3782945A (en) | Mercaptotetrazaindene in photographic printing plate development | |
| US3297445A (en) | Photographic inhibitor releasing developers | |
| US4038075A (en) | Development of photographic silver halide material | |
| US3705806A (en) | Polyquaternary ammonium bisulfites,sulfites and pyrosulfites as developer preservatives | |
| US3671247A (en) | Development of silver halide photographic materials | |
| US4634660A (en) | Development-processing method for silver halide photographic light-sensitive material | |
| US3240603A (en) | Photographic developer solution containing non-sludging silver halide solvent | |
| JPS6047576B2 (ja) | ハロゲン化銀写真感光材料 | |
| JP2736223B2 (ja) | 超硬調画像の作成方法 | |
| US3650759A (en) | Silver halide emulsion containing 1.2-glycol as sensitizer and antifoggant | |
| US3169863A (en) | Pentaerythritol phosphoric acid ester sensitizers for photographic emulsions | |
| US3749574A (en) | Development of photographic silver halide elements | |
| US3713827A (en) | Process for the development of photographic material | |
| US3396022A (en) | Quinone stabilizers and antifoggants for silver halide emulsions | |
| JPS63172267A (ja) | ハロゲン化銀写真乳剤 | |
| US3804624A (en) | Method for developing silver halide photosensitive material | |
| US4078932A (en) | Hardening developers for silver halide photography | |
| US5470699A (en) | Hardening of gelatin-containing layers |